tiprankstipranks
AstraZeneca Announces Share Capital and Voting Rights
Company Announcements

AstraZeneca Announces Share Capital and Voting Rights

AstraZeneca (GB:AZN) has released an update.

Don't Miss our Black Friday Offers:

AstraZeneca PLC, a leading biopharmaceutical company, announced its current share capital with voting rights stands at 1,550,317,189 ordinary shares. This information, disclosed under UK Financial Conduct Authority rules, is crucial for shareholders assessing their investment stakes. AstraZeneca continues to be a global player in the development and commercialization of innovative medicines.

For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAstraZeneca announces results from CAPItello-281 trial
TheFlyAstraZeneca’s Truqap combo demonstrated statistically significant improvement
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App